
Capecitabine Tablets
| Product/Composition | Capecitabine Tablets |
|---|---|
| Strength | 500mg |
| Form | Tablets |
| Production Capacity | 10 Million Tablets/Month |
| Packaging | 1 X 10 Tablets / Box |
| Therapeutic use | Anti Cancer |
| Package Insert/Leaflet | Available upon request |
Capecitabine Tablets
Category: Antimetabolite / Oral chemotherapy
Form: Oral tablets
Uses:
-
Treatment of breast cancer (especially after failure of other chemotherapy or in metastatic cases).
-
Treatment of colorectal cancer, including adjuvant therapy after surgery and metastatic disease.
-
Sometimes used in combination with other chemotherapy drugs (e.g., oxaliplatin, docetaxel).
Mechanism of Action:
-
Capecitabine is a prodrug that is converted in the body to 5-fluorouracil (5-FU).
-
5-FU interferes with DNA synthesis by inhibiting the enzyme thymidylate synthase, preventing cancer cell replication.
-
Selectively activated in tumor tissue due to higher levels of certain enzymes, leading to more targeted action.
Administration:
-
Taken orally with food (usually within 30 minutes after a meal).
-
Given in treatment cycles, e.g., 2 weeks on treatment followed by 1 week off.
-
Dosage is based on body surface area, cancer type, and patient tolerance.
Side Effects:
-
Common: diarrhea, nausea, vomiting, loss of appetite, fatigue, abdominal pain.
-
Hand-foot syndrome (palmar-plantar erythrodysesthesia): redness, swelling, pain, or peeling of skin on palms and soles.
-
Hematologic: low white blood cells, low platelets, anemia.
-
Other: mouth sores, increased liver enzymes, rash.
-
Rare but serious: severe diarrhea, heart problems (e.g., chest pain, arrhythmias), severe infections due to low immunity.
Precautions:
-
Not recommended during pregnancy or breastfeeding due to risk of fetal harm.
-
Kidney function should be checked, as dose adjustments may be needed in renal impairment.
-
Careful monitoring of blood counts and liver function during treatment.
-
Patients should maintain good hydration and report early signs of severe diarrhea or hand-foot syndrome.
Summary:
Capecitabine Tablets are an oral chemotherapy drug used mainly in breast and colorectal cancers. It works as a prodrug of 5-FU, interfering with DNA synthesis in cancer cells. Taken in cycles, it allows outpatient treatment but requires careful monitoring. The most notable side effects are hand-foot syndrome, diarrhea, and bone marrow suppression, which may require dose adjustments.